Correlation Between Access Blood Flow and Extracorporeal Blood Flow
NCT ID: NCT00522704
Last Updated: 2014-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2008-03-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maximizing Native Arteriovenous Fistulae Rates.
NCT02705417
Relationship Between Arterial Variations and Patency of Arteriovenous Fistulae
NCT04613115
Effects of Aerobic Exercise on Arteriovenous Fistula
NCT04015674
The Role of Doppler Ultrasound in Assessment of Local Factors Affecting Maturation of Arteriovenous Fistula in Hemodialysis Patient
NCT05082792
Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients
NCT02874391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynamic Arterial line Pressure (DALP)
eEBF will be record with dynamic arterial line pressure of -60 mmHg (eEBF-60 mmHg), -100 mmHg (eEBF-100 mmHg), -160 mmHg (eEBF-160 mmHg), -200 mmHg (eEBF-200 mmHg) and -260 mmHg (eEBF-260 mmHg) during the first one half hour of the dialysis session. Access Blood flow will be performed with blood thermal monitor.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Permanent vascular accesses with native arteriovenous fistulas (AVF)
* AVF that were at least 12 weeks old
Exclusion Criteria
* Negation to participate in the study
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
JOSE CARRASCO ARTEAGA HOSPITAL FROM Ecuadorian Institute of Social Security
UNKNOWN
Instituto Nacional de Cardiologia Ignacio Chavez
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
FRANKLIN MORA
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franklin B Mora, M.D.
Role: PRINCIPAL_INVESTIGATOR
HOSPITAL JOSE CARRASCO ARTEAGA DEL INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL REGIONAL 3
Luis R Mariscal, M.D.
Role: STUDY_CHAIR
Instituto Nacional de Cardiología Ignacio Chávez
Guadalupe C De la Cruz, R.N.
Role: STUDY_CHAIR
Instituto Nacional de Cardiología Ignacio Chávez
Héctor G Pérez-Grovas, M.D.
Role: STUDY_CHAIR
Instituto Nacional de Cardiología Ignacio Chávez
Fabián H Ortiz, MsC
Role: PRINCIPAL_INVESTIGATOR
Hospital Clínica Kennedy, Guayaquil Ecuador
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Nacional De Cardiología Ignacio Chávez
Mexico City, Distrito Federeal, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INCich-07-08-7403
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.